These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18382359)

  • 1. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
    Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
    Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
    Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
    Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines.
    Whyte DB; Holbeck SL
    Biochem Biophys Res Commun; 2006 Feb; 340(2):469-75. PubMed ID: 16376301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare PIK3CA hotspot mutations in carcinomas of the biliary tract.
    Riener MO; Bawohl M; Clavien PA; Jochum W
    Genes Chromosomes Cancer; 2008 May; 47(5):363-7. PubMed ID: 18181165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of AKT protein kinase activation on biologic behavior of diffuse large B cell lymphoma cells].
    Zhang TC; Zhou XY; Yu BH; Zhang TM; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2007 May; 36(5):318-23. PubMed ID: 17706139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations.
    Hafner C; Landthaler M; Vogt T
    Exp Dermatol; 2010 Aug; 19(8):e222-7. PubMed ID: 20557351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
    Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
    Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
    Cillessen SA; Hess CJ; Hooijberg E; Castricum KC; Kortman P; Denkers F; Vos W; van de Wiel MA; Schuurhuis GJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Clin Cancer Res; 2007 Dec; 13(23):7012-21. PubMed ID: 18056177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population.
    Abubaker J; Bavi P; Al-Harbi S; Ibrahim M; Siraj AK; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    Oncogene; 2008 Jun; 27(25):3539-45. PubMed ID: 18193083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors.
    Lin Y; Jiang X; Shen Y; Li M; Ma H; Xing M; Lu Y
    Endocr Relat Cancer; 2009 Mar; 16(1):301-10. PubMed ID: 18852163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CA mutations in glioblastoma multiforme.
    Hartmann C; Bartels G; Gehlhaar C; Holtkamp N; von Deimling A
    Acta Neuropathol; 2005 Jun; 109(6):639-42. PubMed ID: 15924253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines.
    Hollestelle A; Elstrodt F; Nagel JH; Kallemeijn WW; Schutte M
    Mol Cancer Res; 2007 Feb; 5(2):195-201. PubMed ID: 17314276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA gene mutations in pediatric and adult glioblastoma multiforme.
    Gallia GL; Rand V; Siu IM; Eberhart CG; James CD; Marie SK; Oba-Shinjo SM; Carlotti CG; Caballero OL; Simpson AJ; Brock MV; Massion PP; Carson BS; Riggins GJ
    Mol Cancer Res; 2006 Oct; 4(10):709-14. PubMed ID: 17050665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
    Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
    Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients.
    Tanaka Y; Kanai F; Tada M; Asaoka Y; Guleng B; Jazag A; Ohta M; Ikenoue T; Tateishi K; Obi S; Kawabe T; Yokosuka O; Omata M
    Oncogene; 2006 May; 25(20):2950-2. PubMed ID: 16331247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma.
    Kastrup IB; Worm J; Ralfkiaer E; Hokland P; Guldberg P; Grønbaek K
    Eur J Haematol; 2008 Jan; 80(1):61-6. PubMed ID: 18028428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA mutations in advanced ovarian carcinomas.
    Wang Y; Helland A; Holm R; Kristensen GB; Børresen-Dale AL
    Hum Mutat; 2005 Mar; 25(3):322. PubMed ID: 15712344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
    Shibata T; Kokubu A; Tsuta K; Hirohashi S
    Cancer Lett; 2009 Oct; 283(2):203-11. PubMed ID: 19394761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma.
    Cui W; Cai Y; Wang W; Liu Z; Wei P; Bi R; Chen W; Sun M; Zhou X
    J Transl Med; 2014 Jan; 12():10. PubMed ID: 24418330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
    Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.